drugset / Trial / NCT06578039
Phase 1 Clinical Trial of CordSTEM-ST
Non-randomizedSequentialOpen-labelTreatment
Summary
This clinical study will evaluate the safety and tolerability of CordSTEM-ST after administering a single dose in patients with premature ovarian insufficiency (POI), as well as identify the maximum tolerated dose (MTD) and evaluate the potential therapeutic effects.
Timeline
- Start
- 2024-08-30
- Primary completion
- 2025-04-28
- Completion
- 2025-04-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | umbilical cord-derived mesenchymal stem cell | Cell therapy | — | — |